Beyond Apps and Exposure: Why Participant Adherence Begins With Readiness

For years, the clinical trial industry has been sold an appealing idea: Participant adherence is largely a problem that can be solved with better tools and digital access. Build an app, launch a portal, send reminders, and better participant behavior will follow.

At the same time, the industry has relied on a second assumption that is rarely examined closely: If participants are given simple information, understand the protocol, and complete training, adherence will naturally improve.

There is some truth in both ideas. Technology can reduce friction, improve access, and support communication. Education can build awareness and clarify expectations. But neither one should be mistaken for readiness.

That is the real issue.

Digital tools and participant education are often treated as solutions to adherence, but both are better understood as forms of exposure. One exposes participants to prompts and systems. The other exposes them to information. Neither, on its own, ensures that participants are ready to act consistently in the complexity of everyday life.

And that is where so many adherence strategies fall short.

Participants do not live inside protocols. They live inside real lives: changing schedules, work demands, symptom burden, family responsibilities, stress, fatigue, and the countless interruptions that make even simple health behaviors harder to sustain. In that context, adherence is not simply a function of access, reminders, or information. It is a function of readiness.

Participant adherence does not magically emerge from new technology or better systems, nor does it result from check-the-box education. It depends on the combination of knowledge, calibrated confidence, and real-world mastery, because participants do not simply need to understand the protocol. They need the readiness to carry it out consistently amid the complexity of everyday life.

This distinction matters. A participant may receive reminders and still fail to act. A participant may complete training and still be unprepared for disruption, uncertainty, or routine breakdown. A participant may even sound confident and still lack the capability to perform reliably when life gets messy.

That is because exposure is not execution.

Participants need knowledge, because they must understand what the protocol requires, why it matters, and what to do when something changes. They need confidence, but only when it is calibrated, grounded in a realistic sense of what they know and what they do not. And they need mastery, the practical ability to carry out required behaviors accurately, flexibly, and reliably under real-world conditions.

Together, these create readiness. And readiness is what makes adherence possible.

Digital apps and tools can support readiness. Education can contribute to readiness. But neither should be treated as a proxy for it. If trial sponsors want to improve adherence, the better question is not whether participants were informed or reminded. It is whether they were prepared to succeed in the conditions in which adherence must actually occur.

In the end, adherence is not the byproduct of technology or exposure. It is the result of readiness.

Brian S. McGowan, PhD, FACEHP, is chief learning officer and cofounder of ArcheMedX, Inc.